Executive record

Ellen Strahlman, M.D.

Director at HYPERION DEFI, INC.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:ellen-strahlman-m-dVersion: public-0As of: 2026-09-28

Not yet claimed7 published Claims3 sources
  • Director

Key Claims

Biography

Ellen Strahlman, M.D. has been a Board member since July 2022 and brings extensive C-suite leadership experience in life sciences product innovation and commercialization. She previously served as Executive Vice President of R&D and Chief Medical Officer at Becton Dickinson and Chief Medical Officer at GlaxoSmithKline, with board service at Altria Group and Syncona Limited.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. HYPD DEF 14A director slate

    sec filing · Source published: Jul 24, 2025 · Retrieved: May 16, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Board role: Board role: Director · Claim reviewed: May 16, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  2. Open source

    sec proxy · Source published: Jul 24, 2025 · Retrieved: Apr 28, 2026

    Supports 1 claim
    • Professional Role: Director at HYPERION DEFI, INC. · Claim reviewed: May 16, 2026

  3. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of HYPERION DEFI, INC. · Claim reviewed: May 16, 2026